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Article Highlights    20 
Type of Research: Retrospective analysis of prospectively collected registry data,  21 
Key Findings: 15 patients with a hyperdynamic capill ry-venule malformation have been 22 
retrospectively analyzed. Anomalous dilated superficial veins with uncommon appearance in 23 
 2
size and location with regard to classical primary varicose veins and hypertrophy of the affected 1 
tissue were found in 80% of the patients. 2 
Take Home Message: To prevent ineffective and unnecessary therapy and complications, clinical 3 
suspicion is needed to recognize a hyperdymanic capillary-venule malformation 4 
 5 
Table of Contents Summary   6 
15 patients with a hyperdynamic capillary-venule malformation have been analyzed with the 7 
focus on demographics, clinical presentation and localization. Anomalous dilated superficial 8 
veins with uncommon appearance in size and location w th regard to classical primary varicose 9 




Objective: To describe typical clinical presentation of patients with microfistular, capillary- 14 
venule (CV) malformation as a variant form of arterio-venous malformations (AVM).  15 
Methods: A retrospective clinical analysis of 15 patients with CV-AVM confirmed by a 16 
computational flow model enrolled in a prospective database of patients with congenital vascular 17 
malformation between January 2008 and May 2018.   18 
Results: Mean age of patients at first time of presentation was 30 years with balanced gender 19 
ratio. Presentation was dominated by soft tissue hypertrophy (n=12, 80.0%) and atypical varicose 20 
veins (n=11, 73.3%). Anatomical location of enlarged varicose veins gave no uniform pattern 21 
and did not correspond to the typical picture of prima y varicose vein disease. Most often 22 
symptomatic CV-AVM was found at the lower extremities in this series of unselected patients. 23 
 3
The most frequent compartment affected was the subcutis (n=14, 93.3%), involvement of muscle 1 
was recorded in a third and cutis in a fourth of patients. 2 
Conclusions: A high grade of clinical suspicion is needed to recognize CV-AVM and to prevent 3 
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Introduction 15 
Congenital vascular malformations (CVM) are inborne a omalies of the vascular system 16 
1. The prevalence of CVM is approximately 1.5% in the general population 2. Peripheral arterio-17 
venous malformations (AVM) are the least common type of CVM representing less than one 18 
fourth of all CVM 3. A lack of understanding for hemodynamic characteristics of various AVM 19 
types has led to incorrect therapeutic approaches with high complication rates described in the 20 
literature 4, 5. Although various classification systems were proposed6, 7, there are microfistular, 21 
high-flow malformations not fitting into the established schemes 8.22 
 4
Since 2008 the Division of Angiology at the University Hospital Bern has treated 15 patients 1 
with microfistular AVMs 8, which do not fully match to the classification pro osed by Yakes6, 9, 2 
10 or the classification of CVM as defined by the Inter ational Society of Vascular Anomalies11. 3 
Depending on the size, these atypical AVM usually have monophasic high flow in feeding 4 
arteries and continuous flow in draining veins close to the malformation. Main ultrasound 5 
indicator is high vascular density and spontaneous high flow directly in the tissue affected by the 6 
malformation similar to findings seen in hemangiomas12. Digital subtraction angiography (DSA) 7 
shows no typical early venous shunting. Venous drainage is considerably delayed and dispersed 8 
as compared to other types of AVM 14, and even can be missed with insufficient angiographic 9 
technique as it becomes obvious only with long DSA sequences after disappearance of arterial 10 
contrast flow.  11 
Frey et al were the first to describe the hypothesis that the structural pathology of this subgroup 12 
of AVM probably is at the level of capillary venules after assessing multiple types of AVM with 13 
an analyzing program developed for this purpose 13. The model was robust to simulate different 14 
types of AVM and to differentiate classical types in patients 13, 14.  It was shown that CV-AVM 15 
show a particularly slow and dispersive venous shunting behavior that is different from other 16 
high flow AVM and that the anatomical change mathematically should be on the venule side 17 
following the capillary bed. Computational flow simulation suggests that the fistulous paths is 18 
anatomically assigned to the intermediate venous end of the capillary unit (capillary-venule) and 19 
draining venules. 20 
When AVM affect parts of the microcirculation, their angioarchitecture cannot be resolved with 21 
contrast agent-based clinical imaging techniques. The specifically designed computational 22 
biomedical engineering model described by Frey et all was aimed at identifying microvascular 23 
 5
malformation morphologies based on macroscopic contrast ransport patterns. The model 1 
consists of a small network of capillary vessels with a feeding arteriole and draining venule and a 2 
set of prototype malformation morphologies. Flow rates and pressures are computed with a 3 
lumped parameter description of the network, while contrast propagation is determined by 4 
solving the 1D advection-diffusion equation. Among all considered pathological networks, two 5 
lesion types, which correlate with the two most disinctive arteriovenous transport patterns in 6 
patients, one being fast and non-dispersive and a second type exhibiting slow and dispersive 7 
transport, were identified. The model enables the identification of sub-resolution lesions with 8 
current clinical imaging modalities and can be extended to explore further unknown 9 
microvascular AVM morphologies. 10 
Aim of this analysis is to describe typical clinical findings associated with this variant type of 11 
AVM with hyperdynamic, capillary-venule shunting. 12 
 13 
Method 14 
This is a retrospective analysis based on a prospective database consecutively enrolling 15 
patients with CVM at the University Hospital Bern si ce 2008. The database was locked for this 16 
analysis on May 31st 2018. There were 398 patients enrolled at this time point. Those 398 17 
patients where retrospectively reviewed to identify patients with CV-AVM. Criteria to define a 18 
CV-AVM were:  1. hyperdynamic AVM characteristics uing duplex ultrasound and/or magnetic 19 
resonance imaging, 2. delayed venous shunting defined as an occurrence after arterial contrast 20 
transit using DSA (Figures 1;3;4) 13, 14.  21 
 6
Patient selection was performed in a 2-step process. First, the database was filtered by the search 1 
term AVM. Second, DSA of all patients with the filter term AVM were evaluated by two 2 
experienced vascular specialists to select those pati nts with angiographic criteria as defined.  3 
All patients signed a general informed consent (IC)for anonymized data analysis implemented at 4 
the University Hospital Bern since 2013. Patients erolled before 2013 were contacted and 5 
without any exception signed the IC for anonymized data analysis. 6 
Patients with a questionable diagnosis of CV-AVM or CV-AVM in cerebral and spinal region, 7 
patients with a documentation of any denial to furthe  use of patient`s data and patients under 18 8 
years of age at the point of analysis were excluded. 9 
In addition to demographic and disease related information given in the database, information 10 
was cross-checked using hospital charts of patients available.  11 
A publication consent has been signed by all patients needed for the publication of their Figures. 12 
The study was approved by the Ethics Committee of the Canton of Bern (local ethics board 13 
number ID 2016–01503) 14 
 15 
Data collection  16 
 Demographic data collection included gender and age at first diagnosis of CVM. D-dimer 17 
levels were routinely measured in venous blood samples. D-dimers were determined using an 18 
immunoturbidimetrically method  with pathologic result defined as D-dimer > 500µg/l 16, 17 Pain 19 
was recorded using a numeric rating score (NRS) 18. Pain was scored by the patient between 1 20 
and 10 with 1 defined as no pain and 10 as the worst pain the patient could imagine. Signs 21 
related to CVM systematically collected were soft tissue hypertrophy, localized increase in skin 22 
temperature, edema distal to the malformation defined as a palpable swelling produced by 23 
 7
increase of the interstitial volume19. Soft tissue hypertrophy was described as local overgrowth in 1 
an area infiltrated by the CVM compared to the surro nding tissue not infiltrated by visual 2 
estimation. The skin temperature was measured using a thermographic camera, if the temperature 3 
in the region of the malformation was +0.4 C° compared to the surrounding skin, it was defined 4 
as local increase in skin temperature. The anatomical lo ation and the size of anomalous 5 
enlarged venous vessels were systematically recorded and divided in telangiectasias, reticular 6 
veins and varicose veins. Telangiectasias were defined as visible enlargement of small sized 7 
vessels less than 1mm. Reticular veins were defined as 2-3 mm in size, varicose veins were 8 
defined as dilated, elongated, tortuous veins with a diameter of 3 mm or greater. 9 
All patients were classified according to the Schobinger classification 20 a staging system to 10 
define hyperdynamic circulatory signs and symptoms f CVM. Stage I is defined as quiescence 11 
of disease, stage II as local expansion, stage III as destruction of surrounding tissue due to CVM 12 
and stage IV as decompensation as cardiac failure and symptomatic local steal syndrome, 13 
respectively.  14 
On first presentation the anatomical location and hemodynamic characterization of the lesion 15 
was recorded.  CVM were distinguished into high-flow r low-flow using duplex sonography. 16 
Localization and infiltration were defined by magnetic resonance imaging. 17 
Anatomically upper extremity, lower extremity, trunk and neck/face were distinguished. Tissue 18 
compartments infiltrated were separated into cutis, subcutis, muscle, bone and organs.  19 
 20 
Statistical methods 21 
 The research data were collected in ClinicWinData (E&L medical systems, Germany) 22 
and transferred to excel  (Microsoft, Redmond, Washington, U.S.).  The file has been stored on a 23 
 8
SharePoint 2013 (Microsoft, Redmond, Washington, U.S.) platform that was centrally set up by 1 
the Clinical Trial Unit Bern. It fulfills all requirements of the Human Research Act (HRA). 2 
Continuous variables are presented as mean ± standard deviation (SD) and minimun to 3 
maximum values (min-max). Categorical variables are presented as numbers and percent. 4 
 5 
Results 6 
 Filtering the database for the search term AVM, there were 67 patients (67/398, 16.8%) 7 
identified in the Bernese CVM cohort. In all patiens AVM was verified by DSA. DSAs were 8 
analyzed by two experienced vascular specialists and 15 patients (15/67; 22.4%) were identified 9 
to have CV-AVM. Demographic data among these 15 patients are shown in Table I.  Mean age 10 
at first time of presentation was 30 years.  11 
  12 
Clinical presentation 13 
The NRS pain score was in the lower third and gave a mean of 2.7 ± 0.9 (1 to 4).  On first 14 
presentation 12 patients (80.0%) were diagnosed with soft tissue hypertrophy, 11 (73.3%) had 15 
objectively verified local increase in skin temperatu e in the region of the CV-AVM, and edema 16 
formation was present in 4 (26.6%), respectively.  17 
Enlarged superficial veins were recorded in 11 (73.3%) patients with the proportion of size 18 
shown in Table II. Starting from a variable location f the CV-AVM with increased venous 19 
drainage instead of venous reflux as mechanism of origin and depending on the drainage area, 20 
the clinical picture gave no uniform pattern and ranged from enlarged trunk or lateral branch 21 
varices to limited localized reticular veins (Figure 2; 5). Duplex sonography showed high 22 
vascular density and spontaneous flow directly in the tissue affected by the malformation 23 
 9
accompanied by a wide range of enlarged superficial veins. Out of all 15 patients one patient had 1 
a Schobinger classification higher than stage 2 with soft tissue hypertrophy, skin destruction, 2 
ulcer and pain in the region of the CV-AVM (Figure 5).3 
 4 
Localization of capillary-venule malformation 5 
Anatomical localization of CV-AVM is given in Table III. Most frequently symptomatic CV-6 
AVM was found at the lower extremity (80.0%) in this series of unselected patients. There were 7 
2 patients (13.3%) with CV-AVM of the upper extremity and one patient (6.6%) with a CV-8 
AVM of the face. None of the patients had a malformation recorded in the region of the body 9 
trunk. One patient presented with multifocal CV-AVM (Figure 5). The most frequent 10 
compartment affected was the subcutis (93.3%), involvement of muscle was recorded in a third 11 
and the cutis in a fourth of patients. In one patient additional bone involvement was seen. Organs 12 
were not recorded to be affected in any of the cases. In 26.6% of patients two or more tissue 13 
compartments were affected by the same CV-AVM. 14 
 15 
Discussion 16 
 This is a detailed clinical description of patients with microfistular AVM, defined as 17 
hyperdynamic capillary-venule malformation (CV-AVM). Most prominent findings were 18 
anomalously dilated superficial veins with uncommon appearance in size and location with 19 
regard to classical varicose veins and  hypertrophy of the affected tissue.  20 
D-dimer levels were moderately elevated and of little use for the diagnosis of CV-AVM. 21 
Although symptoms and signs of chronic venous disease dominated clinically, CV-AVM showed 22 
no relevant accompanying localized intravascular cogulopathy as is typical for venous 23 
 10 
malformation. The finding of low and normal D-dimer l vels is well in accordance that CV-1 
AVM represent a hyperdynamic CVM, although clinically the signs and symptoms of venous 2 
disease were dominating 16, 17, 21.  An increased microfistular flow strains the venous drainage 3 
system that becomes clinically enlarged, but the underlying pathophysiology explains that 4 
classical varicose vein treatment, leaving the CV-AM unaffected, will result in high recurrence 5 
rates.  6 
The majority of subcutaneously located CV-AVM were manifest as a warm, enlarged tissue 7 
mass. The mass effect can be explained by an enlargment of anomalous vessels as well as an 8 
associated soft tissue hypertrophy and fibrosis22, 23, a finding well described in AVM 24.  The 9 
local increase in skin temperature is typically to high flow malformations within the cutis and 10 
subcutis due to shunts skipping the capillary autoregulation and high flow dynamics.  11 
As this analysis does not represent a cross-sectional design, but describes unselected patients 12 
seeking medical attention for symptomatic disease, findings cannot be generalized for all patients 13 
with CV-AVM. In our series findings of anomalous enlarged veins and increased skin 14 
temperature with tissue hypertrophy were the reason for most of the patients to consult a 15 
physician. Hyperdynamic flow characteristics in CV-A M are less obvious as compared to 16 
classical high-flow AVM and therefore a high grade of clinical suspicion is needed. Careful 17 
ultrasound assessment of enlarged trunk or lateral branch varices as well as local reticular vein 18 
collections of unusual appearance or localization has to be performed to detect increased venous 19 
drainage and high vascular density with spontaneous fl w directly in the tissue affected by the 20 
malformation to differentiate CV-AVM from chronic venous insufficiency.  21 
Muliken et al published a subgroup of patients with regional capillary malformation of the lower 22 
extremity in association with phlebectasia. This capill ry venous malformation should not be 23 
 11 
confused with the variant described in this publication. Although both forms have capillary and 1 
venous components, shunt-related high flow is sole characteristic of the latter 15. 2 
Undirected treatment of superficial venous disease is accompanied with a high rate of 3 
recurrences and even bleeding complications. It is important not to overlook the hyperdynamic 4 
perfusion in patients with unusual appearance and location of superficial venous disease to 5 
prevent ineffective procedures.  To treat those enlarged superficial veins based on a CV-AVM 6 
the same way as chronic venous insufficiency in prima y varicose vein disease 25 would be a 7 
predictable error due to the fact that the venous hypertension does not occur due to insufficient 8 
venous valves . The hypertension in veins relates to high pressure due to shunts in the 9 
microcirculation, leading to shear stress followed by the symptoms and signs well known for 10 
chronic venous insufficiency 26 but in unusual anatomical locations. 11 
Therapeutically the CV-AVM has to be removed first, before stripping or sclerotherapy of 12 
varicose veins can be planned 7, 9. Due to the infiltrating character of CV-AVM complete 13 
surgical extraction is often not possible. It was not a main subject of this publication to describe 14 
the treatment of CV-AVM. In brief, all patients were treated with percutaneous injections of 50% 15 
to 96% ethanol to hit the nidus 3, 4. Treatment of CV-AVM is particularly laborious due to its 16 
diffuse character and often innumerable venules attribu ed to the nidus  17 
 18 
Conclusion  19 
 Patients with the capillary-venule variant of AVM seem to become clinically apparent 20 
with enlarged superficial veins of atypical appearance and tissue hypertrophy with increased 21 
overlying skin temperature. Referral was most often or management of chronic venous 22 
insufficiency after treatment failure, soft tissue hypertrophy and local pain. To prevent 23 
 12 
ineffective and unnecessary therapy and complications clinical suspicion is needed to recognize 1 
the diagnosis. Description of an individualized trea ment plan exceeds the focus of this study. To 2 
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Table I 
Characteristics  
Female, N (%) 7 (46.6) 
Age, mean±SD (min-max), years 29.7±23.0 (1.0-81.0) 
D-Dimer, mean±SD; (min-max), µg/l 677.8±647.1  (81.0-2071.0) 
 
Legend: Demographic data of patients with capillary-venulous malformation  
  
Table II  
  N (%) 
Total 11 (73.3) 
Telangiectasias 6 (40.0) 
Reticular veins 5 (33.3) 
Varicose veins 5 (33.3) 
 
Legend: Appearance of enlarged atypical superficial veins 
  
Table III 
Compartment N (%) 
Subcutis 14  (93.3) 
Muscle 5 (33.3) 
Cutis 4  (26.6) 
Bone  1 (6.6) 
Organs none 
 
Legend: Tissue involvement in patients with capillary-venulous malformation 
 
Figure Legends 1 
 2 
Figure 1: Patient 1; Digital subtraction angiography of a 58-year old patient with late shunting 3 
typically for CV-AVM. 4 
Figure 2: Patient 1; Right leg of a 58-year old patient with dermatosclerosis and extensive 5 
recurrent varicose veins 6 
Figure 3: Patient 2; Digital subtraction angiography of a 78-year old patient of the right foot. 7 
Figure 4: Patient 2; Digital subtraction angiography of a 78-year old patient of the left foot.  8 
Figure 5: Patient 2; Right leg of a 78-year old patient, with a severe form of CV-AVM with 9 
Schobinger stage 3 and a second, multifocal lesion at the dorsum of his left foot. 10 
 11 
Table Legends 12 
Table I: Demographic data of patients with capillary-venule malformation  13 
Table II: Appearance of enlarged atypical superficial veins 14 
Table III: Tissue involvement in patients with Capillary-venule malformation malformation 15 





